Meningeal dissemination from an ovarian carcinoma with effective response to intrathecal chemotherapy

Demopoulos A (2004) Leptomeningeal metastases. Curr Neurol Neurosci Rep 4:196–204

Jayson GC, Howell A (1996) Carcinomatous meningitis in solid tumours. Ann Oncol 7:773–786

Ohta H, Koyama R, Nagai T, et al. (2001) Meningeal carcinomatosis from an ovarian primary with complete response to adjuvant chemotherapy after cranial irradiation. Int J Clin Oncol 6: 157–162

Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759–772

Phuphanich S, Maria B, Braeckman R, et al. (2007) A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt(R)) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. J Neurooncol 81:201–208

Sandberg DI, Bilsky MH, Souweidane MM, et al. (2000) Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47:49–54

Gordon AN, Kavanagh JJ Jr, Wharton JT, et al. (1984) Successful treatment of leptomeningeal relapse of epithelial ovarian cancer. Gynecol Oncol 18:119–124

Yoshida S, Morii K (2005) Intrathecal chemotherapy for patients with meningeal carcinomatosis. Surg Neurol 63:52–55

Kim DY, Lee KW, Yun T, et al. (2003) Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 33:608–612

Glantz MJ, Jaeckle KA, Chamberlain MC, et al. (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5: 3394–3402

Fizazi K, Asselain B, Vincent-Salomon A, et al. (1996) Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 77:1315–1323

Nakagawa H, Murasawa A, Kubo S, et al. (1992) Diagnosis and treatment of patients with meningeal carcinomatosis. J Neurooncol 13:81–89

Hitchins RN, Bell DR, Woods RL, Levi JA (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5:1655–1662